- Home
- PRG vs BCRX Comparison
PRG vs BCRX Comparison
Compare PRG & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRG
- BCRX
- Stock Information
- Founded
- PRG 2020
- BCRX 1986
- Country
- PRG United States
- BCRX United States
- Employees
- PRG N/A
- BCRX N/A
- Industry
- PRG Diversified Commercial Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRG Consumer Discretionary
- BCRX Health Care
- Exchange
- PRG Nasdaq
- BCRX Nasdaq
- Market Cap
- PRG 2.0B
- BCRX 1.7B
- IPO Year
- PRG N/A
- BCRX 1994
- Fundamental
- Price
- PRG $46.58
- BCRX $7.29
- Analyst Decision
- PRG Buy
- BCRX Strong Buy
- Analyst Count
- PRG 6
- BCRX 5
- Target Price
- PRG $53.00
- BCRX $15.60
- AVG Volume (30 Days)
- PRG 374.1K
- BCRX 2.4M
- Earning Date
- PRG 10-23-2024
- BCRX 11-04-2024
- Dividend Yield
- PRG 1.02%
- BCRX N/A
- EPS Growth
- PRG 8.67
- BCRX N/A
- EPS
- PRG 3.58
- BCRX N/A
- Revenue
- PRG $2,417,577,000.00
- BCRX $412,579,000.00
- Revenue This Year
- PRG $2.94
- BCRX $37.24
- Revenue Next Year
- PRG $6.29
- BCRX $19.30
- P/E Ratio
- PRG $13.10
- BCRX N/A
- Revenue Growth
- PRG N/A
- BCRX 29.92
- 52 Week Low
- PRG $26.39
- BCRX $4.03
- 52 Week High
- PRG $50.28
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- PRG 50.21
- BCRX 43.18
- Support Level
- PRG $46.18
- BCRX $6.92
- Resistance Level
- PRG $48.59
- BCRX $7.51
- Average True Range (ATR)
- PRG 1.35
- BCRX 0.44
- MACD
- PRG 0.02
- BCRX -0.07
- Stochastic Oscillator
- PRG 50.96
- BCRX 22.86
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The Company has two reportable segments: (i) Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and (ii) Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the progressive leasing segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.